Article Sidebar

Published: 2025-09-18
Abstract Views: 3
DOI: https://doi.org/10.52163/yhc.v66iCD14.3140
Issue
Tập 66 Số CĐ14-HNKH Bệnh viện Giao thông vận tải
Section
Articles
How to Cite
Nhật, T. T. B., Hào, N. T., Hiệu, N. M., Quynh, V. V., Pol, N. V., Vy, Đoàn T., Nhân, N. Đình, & Trung, V. Q. (2025). 34. MEDICATION USE AND COST OF HEART FAILURE TREATMENT IN 2022: A STUDY AT A GRADE I HOSPITAL, HO CHI MINH CITY. Vietnam Journal of Community Medicine, 66(CD14). https://doi.org/10.52163/yhc.v66iCD14.3140

34. MEDICATION USE AND COST OF HEART FAILURE TREATMENT IN 2022: A STUDY AT A GRADE I HOSPITAL, HO CHI MINH CITY

Tran Thi Bich Nhat1, Nguyen Trong Hao2, Nguyen Minh Hieu3, Vu Van Quynh4, Nguyen Van Pol4, Doan Thao Vy5, Ngo Dinh Nhan6, Vu Quang Trung7
1 Faculty of Pharmacy, Pham Ngoc Thach University of Medicine, Ho Chi Minh City
2 Faculty of Medicine, Pham Ngoc Thach University of Medicine, Ho Chi Minh City
3 Policy Management Board, Political Department, Military Hospital 175
4 Faculty of Pharmacy, Pham Ngoc Thach University of Medicine
5 Nguyen Thuong Hien High School, Ho Chi Minh City.
6 Department of Drug Administration, Ministry of Health.
7 Faculty of Pharmacy, Pham Ngoc Thach University of Medicine.

Main Article Content

Abstract

Introduction: Heart failure represents a significant global public health concern, particularly among the elderly population. Furthermore, the economic burden associated with heart failure poses a substantial challenge to healthcare systems worldwide, including Vietnam.


Objective: To analyze the economic burden of heart failure based on direct medical costs from a hospital perspective.


Method: A retrospective analysis was conducted using electronic medical records of heart failure’ inpatients at Military Hospital 175 during 2022. Patients with heart failure as the primary diagnosis were included in the analytical dataset. The study estimated the cost burden based on healthcare services utilized within the hospital setting.


Results: The study comprised 312 heart failure’ inpatients with a mean age of 67.1 ± 14.9 years. The total treatment cost for heart failure amounted to 7,199,653,394 VND, with the majority covered by health insurance. Pharmaceuticals, infusions, and medical supplies constitute the highest proportion of expenditures. Magnesium and potassium supplements represented the largest pharmaceutical expenditure at 75,408,753 VND (4.01% of total costs).


Conclusion: The findings provide healthcare administrators with a comprehensive overview of heart failure-related expenditures, thereby facilitating the development of appropriate strategies for management and allocation of healthcare resources for heart failure treatment.

Article Details

Keywords

cost of illness, direct medical costs, heart failure, inpatients.

References

[1] Đỗ Thị Nam Phương and Nguyễn Anh Duy Tùng. Khảo sát các yếu tố tiên lượng tử vong trên bệnh nhân suy tim phân suất tống máu giảm nhập viện tại Viện Tim TPHCM. 2019 29/05/2022]; Available from: https://timmachhoc.vn/khao-sat-cac-yeu-to-tien-luong-tu-vong-tren-benh-nhan-suy-tim-phan-suat-tong-mau-giam-nhap-vien-tai-vien-tim-tp-hcm/.
[2] P. A. Heidenreich, N. M. Albert, L. A. Allen, D. A. Bluemke, J. Butler, G. C. Fonarow, J. S. Ikonomidis, O. Khavjou, M. A. Konstam, and T. M. Maddox, Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circulation: Heart Failure, 2013. 6(3): p. 606-619.
[3] E. B. Reyes, J.-W. Ha, I. Firdaus, A. M. Ghazi, A. Phrommintikul, D. Sim, Q. N. Vu, C. W. Siu, W.-H. Yin, and M. R. Cowie, Heart failure across Asia: same healthcare burden but differences in organization of care. International journal of cardiology, 2016. 223: p. 163-167.
[4] Bộ Y tế. Các yếu tố nguy cơ dẫn đến bệnh tim mạch. 2015 29/04/2023]; Available from: https://moh.gov.vn/chuong-trinh-muc-tieu-quoc-gia/-/asset_publisher/7ng11fEWgASC/content/cac-yeu-to-nguy-co-dan-en-benh-tim-mach?inheritRedirect=false#:~:text=Nh%C3%ACn%20chung%2C%20nam%20gi%E1%BB%9Bi%20c%C3%B3,ph%E1%BB%A5%20n%E1%BB%AF%20l%C3%A0%20nh%C6%B0%20nhau.
[5] E. Kim, H.-Y. Kwon, S. H. Baek, H. Lee, B.-S. Yoo, S.-M. Kang, Y. Ahn, and B.-M. Yang, Medical costs in patients with heart failure after acute heart failure events: one-year follow-up study. Journal of Medical Economics, 2018. 21(3): p. 288-293.
[6] S. C. Ong, J. Z. Low, W. Y. Yew, C. H. Yen, M. A. S. A. Kader, H. B. Liew, and A. K. A. Ghapar, Cost analysis of chronic heart failure management in Malaysia: A multi-centred retrospective study. Frontiers in Cardiovascular Medicine, 2022. 9.